Clinical Trials in San Francisco

Showing 7181-7200 of 9,883 trials

Urine pH and Diet Net Acid Load

NCT02116595

Presently, the gold standard for testing diet acid intake is a urine collection done for many hours, usually 24 hours, which must be analyzed in a research lab for "net acid excretion". So, getting information about diet acid intake is difficult. Many people have suggested doing a much simpler test, which is checking the pH of the urine when you wake up. But, no one has studied if this simpler method is a valid method for estimating the 24 hour net acid excretion. Diet acid load may be important in many diseases associated with aging, such as loss of bone and muscle, and the development of kidney disease.

Healthy

University of California, San FranciscoStarted Jan 2015

San Francisco, California, United States

COMPLETEDNA< 1 mile

Accuracy of Methemoglobin Measurement for Rainbow Universal Pulse Oximeter Sensor

NCT03125005

In this study, the level of methemoglobin (HbMet) will be increased in a controlled manner by administering sodium nitrite intravenously in healthy volunteers. The accuracy of a noninvasive HbMet sensor will be assessed by comparison to blood measurements from a laboratory analyzer.

Healthy

Masimo Corporation51 participantsStarted Apr 2012

Irvine, California, United States • San Francisco, California, United States

COMPLETEDPhase 1< 1 mile

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

NCT02494024

This study will evaluate the safety and tolerability (maximum tolerated dose (MTD) within the specified dosing range) of single intravenous (IV) infusion of C2N-8E12 in patients with progressive supranuclear palsy (PSP).

Progressive Supranuclear Palsy

C2N Diagnostics32 participantsStarted Jul 2015

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Los Angeles, California, United States +9 more locations

Urine pH and Diet Net Acid Load

Accuracy of Methemoglobin Measurement for Rainbow Universal Pulse Oximeter Sensor

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

Find Trials by Condition in San Francisco

Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF

Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

Partnership for Rapid Elimination of Trachoma

Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery

Promoting Sleep to Prevent Substance Use in Adolescence

Effectiveness of the Quotient® ADHD Assessment in a System of Care

Genetic Biomarkers of Executive Stress

Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer

Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)

POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational Study

Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015

A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database

Mastectomy Reconstruction Outcomes Consortium (MROC) Study